Mariusz Puszczewicz
Overview
Explore the profile of Mariusz Puszczewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zebryk P, Przymuszala P, Nowak J, Piorunek T, Mularek-Kubzdela T, Puszczewicz M
J Clin Med
. 2023 Jan;
12(2).
PMID: 36675584
We evaluated the prevalence of systemic sclerosis (SSc)-related autoantibodies and their clinical significance and compared the sensitivity of two line immunoblot assays on a prospective study group of 96 Polish...
2.
Niklas K, Niklas A, Mularek-Kubzdela T, Puszczewicz M, Samborski W
Postepy Dermatol Alergol
. 2022 Dec;
39(5):880-886.
PMID: 36457689
Introduction: Microvascular changes play a significant role in systemic sclerosis (SSc) and mixed connective tissue disease (MCTD). The most serious complications of SSc and MCTD are lung fibrosis (LF) and...
3.
Rzeszotarska E, Sowinska A, Stypinska B, Lutkowska A, Felis-Giemza A, Olesinska M, et al.
Clin Exp Rheumatol
. 2022 Jan;
40(9):1708-1717.
PMID: 35084314
Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease, and IL-1β, IL-10, and TNF-α genes are important in the pathogenesis of this disease. We studied the impact of IL-1β-511, IL-1β...
4.
Runowska M, Majewski D, Majewska K, Puszczewicz M
Reumatologia
. 2021 Sep;
59(3):146-152.
PMID: 34538941
Objectives: In rheumatic diseases, vitamin D supply is recommended as part of the prophylaxis and treatment of osteoporosis, especially in patients undergoing glucocorticoid therapy, but also due to its immunoregulatory...
5.
Runowska M, Majewski D, Puszczewicz M
Postepy Dermatol Alergol
. 2021 Aug;
38(2):335-337.
PMID: 34408600
No abstract available.
6.
Grygiel-Gorniak B, Majewski D, Limphaibool N, Puszczewicz M
Pol Arch Intern Med
. 2020 Sep;
130(12):1097-1098.
PMID: 32877154
No abstract available.
7.
Rzeszotarska E, Sowinska A, Stypinska B, Walczuk E, Wajda A, Lutkowska A, et al.
Biomolecules
. 2020 Mar;
10(3).
PMID: 32214033
Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disease. SLE is described by production of autoantibodies and causes damage of many organs. T-cells play a crucial role in...
8.
Grygiel-Gorniak B, Ziolkowska-Suchanek I, Kaczmarek E, Puszczewicz M, Rozwadowska N
J Immunol Res
. 2020 Feb;
2020:7509608.
PMID: 32090130
Peroxisome proliferator-activated receptors () and beta-3-adrenergic receptors () are involved in the risk of hypertension. But their exact role in blood pressure modulation in patients with connective tissue diseases (CTD)...
9.
Niklas K, Niklas A, Puszczewicz M
Postepy Dermatol Alergol
. 2019 Dec;
36(5):646-647.
PMID: 31839786
No abstract available.
10.
Czekalska A, Majewski D, Puszczewicz M
Reumatologia
. 2019 Sep;
57(4):214-220.
PMID: 31548748
Biological disease-modifying antirheumatic drugs target specific components of the immune response related to pathogenesis of autoimmune and inflammatory diseases. Introduction of biologic therapies has enabled better disease control than conventional...